September 13—Baltimore, Maryland— Tracy Ryan, co-founder of NKore Biotherapeutics, will give a keynote talk tomorrow in the analytical meeting room at 9:00 a.m. The talk is titled “Saving Sophie: One Mom’s Journey to Find a Cure Using Cannabis and Cell Therapy” and will be presented remotely on video.
Tracy Ryan, co-founder of NKore Biotherapeutics, will give a keynote talk tomorrow in the analytical meeting room at 9:00 a.m. The talk is titled “Saving Sophie: One Mom’s Journey to Find a Cure Using Cannabis and Cell Therapy” and will be presented remotely on video.
Tracy Ryan’s 9-year-old daughter Sophie has battled a low-grade brain tumor since she was an infant. Sophie’s journey using cannabis is featured in the Ricki Lake Netflix documentary, Weed the People. After seeing unexplainable successes with Sophie, they spent the next 8 years helping patients globally through their brand CannaKids. Research was the next step since cannabis wasn’t fully eradicating Sophie’s tumor, but immunologically it was profound. Tracy has since co-founded the cancer immunotherapy therapeutic and diagnostic company, NKore Biotherapeutics. Since licensing Dr. Anahid Jewett’s suite of patents, backed by 30-years of research, Ryan and Jewett continue their fight to bring non-toxic treatments to patients using Supercharged Natural Killer Cells, cannabis, and probiotics, with curing Sophie as a focus.
Tracy Ryan is the co-founder of NKore Biotherapeutics, a cancer research, diagnostics, and therapeutics company. Ryan is also the founder of CannaKids. Her family is the featured family in the Ricki Lake produced Netflix documentary, Weed the People, that documented their daughter’s journey using cannabis to treat her pediatric brain tumor.
For more information on the analytical track, please visit the 2021 Cannabis Science Conference East Final Program & Exhibitor Guide.
Best of the Week: February 7 – February 13, 2025
February 14th 2025Here, we bring you our top five recent news articles covering announcements from the US Hemp Roundtable, the latest cannabis research studies, and additional editorial commentary on the prevalence of schizophrenia after cannabis legalization.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.